We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The LYNX-2 study is being conducted under conditions of ...

Please provide your email address to receive an email when new articles are posted on . Laru-zova demonstrated a positive safety profile and early efficacy in improving low luminance visual acuity in ...

STOCKHOLM — A real-world analysis of retrospective data showed that administering more anti-VEGF injections over a 5-year time span to treat macular edema secondary to retinal vein occlusion (RVO) was ...